Publications by authors named "Sebastien Morin"

Claim this Profile
I
Increased Throughput of Combined Stability Testing and Metabolite Identification Using a Sample Multiplexing Strategy for the Optimization of Engineered Cyclic Peptide Drugs.
Congliang Sun, Mark T Cancilla, Bahanu Habulihaz, Lisa A Vasicek, Daniel S Spellman, Sebastien Morin

J Am Soc Mass Spectrom· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Accelerating access to paediatric medicines: lessons learned from the Global Accelerator for Paediatric Formulations, a WHO-hosted network.
Martina Penazzato, Asma Hafiz, Sébastien Morin, Farihah Malik, Bernadette Cappello

Lancet Child Adolesc Health· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Access to highly effective long-acting RSV-monoclonal antibodies for children in LMICs-reducing global inequity.
Heather J Zar, Manuele Piccolis, Jonne Terstappen, Natalie I Mazur, Lobna Gaayeb, Sébastien Morin

Lancet Glob Health· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel approaches to enable equitable access to monoclonal antibodies in low- and middle-income countries.
Shelly Malhotra, Anne-Isabelle Cameron, Dzintars Gotham, Esteban Burrone, Peter J Gardner, Sébastien Morin

PLOS Glob Public Health· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Negotiating public-health intellectual property licensing agreements to increase access to health technologies: an insider's story.
Charles Gore, Sébastien Morin, John-Arne Røttingen, Marie Paule Kieny

BMJ Glob Health· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Voluntary licensing of long-acting HIV prevention and treatment regimens: using a proven collaboration- and competition-based mechanism to rapidly expand at-scale, sustainable, quality-assured and affordable supplies in LMICs.
Lobna Gaayeb, Aditi Das, Ike James, Rajesh Murthy, Sandra Nobre, Sébastien Morin

J Int AIDS Soc· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expanding access to biotherapeutics in low-income and middle-income countries through public health non-exclusive voluntary intellectual property licensing: considerations, requirements, and opportunities.
Sébastien Morin, Giulia Segafredo, Manuele Piccolis, Aditi Das, Meghmala Das

Lancet Glob Health· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The economic and public health impact of intellectual property licensing of medicines for low-income and middle-income countries: a modelling study.
Sébastien Morin, Hannah Barron Moak, Oliver Bubb-Humfryes, Christian von Drehle, Jeffrey V Lazarus

Lancet Public Health· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pediatric COVID-19 Therapeutics: Seizing the Right Research and Development Opportunities to Accelerate Access for Children.
Sébastien Morin, Marc Lallemant, Anthony Garcia-Prats, Linda Lewis, Melynda Watkins

Pediatr Infect Dis J· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
relax: the analysis of biomolecular kinetics and thermodynamics using NMR relaxation dispersion data.
Sébastien Morin, Troels E Linnet, Mathilde Lescanne, Paul Schanda, Gary S Thompson

Bioinformatics· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Catalysing the development and introduction of paediatric drug formulations for children living with HIV: a new global collaborative framework for action.
Martina Penazzato, Melynda Watkins, Sébastien Morin, Linda Lewis, Fernando Pascual

Lancet HIV· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment advocate tactics to expand access to antiviral therapy for HIV and viral hepatitis C in low- to high-income settings: making sure no one is left behind.
Céline Grillon, Priti R Krishtel, Othoman Mellouk, Anton Basenko, James Freeman, Sébastien Morin

J Int AIDS Soc· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Shortening the decade-long gap between adult and paediatric drug formulations: a new framework based on the HIV experience in low- and middle-income countries.
Martina Penazzato, Linda Lewis, Melynda Watkins, Vineet Prabhu, Fernando Pascual, Sébastien Morin

J Int AIDS Soc· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Manufacturers' Perspective on World Health Organization Prequalification of In Vitro Diagnostics.
Sébastien Morin, Nelli Bazarova, Philippe Jacon, Stefano Vella

Clin Infect Dis· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elimination of HCV as a public health concern among people who inject drugs by 2030 - What will it take to get there?
Jason Grebely, Gregory J Dore, Sébastien Morin, Jürgen K Rockstroh, Marina B Klein

J Int AIDS Soc· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Highlights from the 3rd international HIV/viral hepatitis Co-infection meeting - HIV/viral hepatitis: improving diagnosis, antiviral therapy and access.
Tongai G Maponga, Rachel Matteau Matsha, Sébastien Morin, Andrew Scheibe, Tracy Swan

Hepatol Med Policy· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aligning Potency and Pharmacokinetic Properties for Pyridine-Based NCINIs.
Lee D Fader, Murray Bailey, Eric Beaulieu, François Bilodeau, Pierre Bonneau, Sebastien Morin

ACS Med Chem Lett· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of Potent, Orally Bioavailable Inhibitors of Human Cytomegalovirus.
Lee Fader, Martine Brault, Jessica Desjardins, Nathalie Dansereau, Louie Lamorte, Sébastien Morin

ACS Med Chem Lett· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination of the CCL5-derived peptide R4.0 with different HIV-1 blockers reveals wide target compatibility and synergic cobinding to CCR5.
Massimiliano Secchi, Lia Vassena, Sébastien Morin, Dominique Schols, Luca Vangelista

Antimicrob Agents Chemother· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
relax: the analysis of biomolecular kinetics and thermodynamics using NMR relaxation dispersion data.
Sébastien Morin, Troels E Linnet, Mathilde Lescanne, Paul Schanda, Gary S Thompson

Bioinformatics· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Minimizing the Contribution of Enterohepatic Recirculation to Clearance in Rat for the NCINI Class of Inhibitors of HIV.
Lee D Fader, Rebekah Carson, Sébastien Morin, François Bilodeau, Catherine Chabot

ACS Med Chem Lett· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of BI 224436, a Noncatalytic Site Integrase Inhibitor (NCINI) of HIV-1.
Lee D Fader, Eric Malenfant, Mathieu Parisien, Rebekah Carson, François Bilodeau, Sébastien Morin

ACS Med Chem Lett· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of potent and orally bioavailable nucleotide competing reverse transcriptase inhibitors: in vitro and in vivo optimization of a series of benzofurano[3,2-d]pyrimidin-2-one derived inhibitors.
Claudio F Sturino, Yves Bousquet, Clint A James, Patrick DeRoy, Martin Duplessis, Sébastien Morin

Bioorg Med Chem Lett· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimization of a 1,5-dihydrobenzo[b][1,4]diazepine-2,4-dione series of HIV capsid assembly inhibitors 1: addressing configurational instability through scaffold modification.
Lee D Fader, Serge Landry, Sébastien Morin, Stephen H Kawai, Yves Bousquet

Bioorg Med Chem Lett· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimization of a 1,5-dihydrobenzo[b][1,4]diazepine-2,4-dione series of HIV capsid assembly inhibitors 2: structure-activity relationships (SAR) of the C3-phenyl moiety.
Lee D Fader, Serge Landry, Sylvie Goulet, Sébastien Morin, Stephen H Kawai

Bioorg Med Chem Lett· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis